Abstract Mutational signatures are key to understanding the processes that shape cancer genomes, yet their analysis requires relatively rich whole-genome or whole-exome mutation data. Recently, orders-of-magnitude sparser gene-panel-sequencing data have become increasingly available in the clinic. To deal with such sparse data, we suggest a novel mixture model, Mix. In application to simulated and real gene-panel sequences, Mix is shown to outperform current approaches and yield mutational signatures and patient stratifications that are in higher agreement with the literature. We further demonstrate its utility in several clinical settings, successfully predicting therapy benefit and patient groupings from MSK-IMPACT pan-cancer data. Availa...
Somatic DNA mutations are a characteristic of cancerous cells, being usually key in the origin and d...
International audienceThe study of genomic DNA alterations (recurrent regions of alteration, pattern...
Mutational signatures have emerged as powerful biomarkers in cancer patients, with prognostic and th...
Mutation signatures in cancer genomes reflect endogenous and exogenous mutational processes, offerin...
BackgroundTumor genomes are often highly heterogeneous, consisting of genomes from multiple subclona...
Cancer is the result of mutagenic processes that can be inferred from tumor genomes by analyzing rat...
Cancer is a disease driven and characterised by mutations in the DNA. Different categorisations of D...
Mutational signatures are patterns of mutations that arise during tumorigenesis. We present an enhan...
Mutational signatures are patterns of mutations that arise during tumorigenesis. We present an enhan...
This dissertation proposes tools and analysis of mutational signatures in human cancer and their app...
Funding Information: The Project is funded by Academy of Finland Grant Nos. 345829 and 322675, Europ...
International audienceMutational signatures refer to patterns in the occurrence of somatic mutations...
The genome of a cancer cell is replete with somatic mutations imprinted by the activities of differe...
Mutational processes acting on cancer genomes can be traced by investigating mutational signatures. ...
Somatic DNA mutations are a characteristic of cancerous cells, being usually key in the origin and d...
International audienceThe study of genomic DNA alterations (recurrent regions of alteration, pattern...
Mutational signatures have emerged as powerful biomarkers in cancer patients, with prognostic and th...
Mutation signatures in cancer genomes reflect endogenous and exogenous mutational processes, offerin...
BackgroundTumor genomes are often highly heterogeneous, consisting of genomes from multiple subclona...
Cancer is the result of mutagenic processes that can be inferred from tumor genomes by analyzing rat...
Cancer is a disease driven and characterised by mutations in the DNA. Different categorisations of D...
Mutational signatures are patterns of mutations that arise during tumorigenesis. We present an enhan...
Mutational signatures are patterns of mutations that arise during tumorigenesis. We present an enhan...
This dissertation proposes tools and analysis of mutational signatures in human cancer and their app...
Funding Information: The Project is funded by Academy of Finland Grant Nos. 345829 and 322675, Europ...
International audienceMutational signatures refer to patterns in the occurrence of somatic mutations...
The genome of a cancer cell is replete with somatic mutations imprinted by the activities of differe...
Mutational processes acting on cancer genomes can be traced by investigating mutational signatures. ...
Somatic DNA mutations are a characteristic of cancerous cells, being usually key in the origin and d...
International audienceThe study of genomic DNA alterations (recurrent regions of alteration, pattern...
Mutational signatures have emerged as powerful biomarkers in cancer patients, with prognostic and th...